EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML)

Silvia Mutti, Alessia Cavalleri, Anna Sicuranza, Paola Pacelli, Claudia Ielo, Lucia Paolini, Valentina Mangolini, Alessandro Leoni, Teresa Miracapillo, Camilla Turriziani, Elisabetta Abruzzese, Mirko Farina und 6 weitere

Stem Cells Translational Medicine · 24.11.2025 · 14 (12)

DOI: 10.1093/stcltm/szaf062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 24.11.2025. Verfasst von Silvia Mutti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Blood Diseases and Bone Marrow Transplant, Department of Clinical and Experimental Sciences (DSCS), Università di Brescia, ASST Spedali Civil…. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Fusion Proteins, bcr-abl, Neoplastic Stem Cells, Dipeptidyl Peptidase 4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union-Next Generation EU, European Union—Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic myeloid leukemia (CML) persists due to leukemic stem cells, notably the CD26+ subset. We investigated correlations between circulating CD26+ leukemic stem cells (LSCs) and BCR::ABL1 transcripts in an extracellular vesicle–enriched secretome (EVES) from plasma samples of 44 CML patients. EVES were characterized and BCR::ABL1 quantified via digital PCR. We observed an inverse correlation between CD26+LSC counts and EVES BCR::ABL1 levels, especially in deep molecular responders (DMR). CD26+LSCs were elevated in patients in treatment-free remission (TFR), while EVES BCR::ABL1 levels were higher in those receiving therapy. These findings suggest distinct dynamics between LSC populations and vesicle-mediated transcript release, with potential implications for CML monitoring and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveFusion Proteins, bcr-ablNeoplastic Stem CellsDipeptidyl Peptidase 4HumansMaleFemaleMiddle AgedAdultExtracellular VesiclesAged

Stichwörter der Autor:innen

BCR::ABL1CD26EVESchronic myeloid leukemialeukemic stem cells

Substanzen

Fusion Proteins, bcr-ablDipeptidyl Peptidase 4DPP4 protein, humanBCR-ABL1 fusion protein, human

Autor:innen und Institutionen

  • Unit of Blood Diseases and Bone Marrow Transplant, Department of Clinical and Experimental Sciences (DSCS), Università di Brescia, ASST Spedali Civili, Brescia 25123, Italy.
  • Centro di Ricerca Emato-Oncologica AIL (CREA), ASST Spedali Civili, Brescia 25123, Italy.
  • Azienda Ospedaliera Universitaria, University of Siena, Siena 53100, Italy.
  • Umberto I Policlinico, La Sapienza University, Rome 00161, Italy.
  • Department of Medical and Surgical Specialties, Radiological Sciences and Public Health (DSMC), Università di Brescia, Brescia, 25123, Italy.
  • Department of Molecular and Translational Medicine (DMMT), Università di Brescia, Brescia 25123, Italy.

ORCID-Profile: Simona Bernardi

Förderung

  • European Union-Next Generation EU
  • European Union—Next Generation EU

Zitieren

APA

Mutti, S., Cavalleri, A., Sicuranza, A., Pacelli, P., Ielo, C., Paolini, L., Mangolini, V., Leoni, A., Miracapillo, T., Turriziani, C., Abruzzese, E., Farina, M., Radeghieri, A., Malagola, M., Breccia, M., Bocchia, M., Russo, D., & Bernardi, S. (2025). Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML). Stem Cells Translational Medicine, 14(12). https://doi.org/10.1093/stcltm/szaf062

Vancouver

Mutti S, Cavalleri A, Sicuranza A, Pacelli P, Ielo C, Paolini L, et al. Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML). Stem Cells Translational Medicine. 2025;14(12). doi:10.1093/stcltm/szaf062

BibTeX
@article{Mutti2025,
  author = {Mutti, Silvia and Cavalleri, Alessia and Sicuranza, Anna and Pacelli, Paola and Ielo, Claudia and Paolini, Lucia and Mangolini, Valentina and Leoni, Alessandro and Miracapillo, Teresa and Turriziani, Camilla and Abruzzese, Elisabetta and Farina, Mirko and Radeghieri, Annalisa and Malagola, Michele and Breccia, Massimo and Bocchia, Monica and Russo, Domenico and Bernardi, Simona},
  title = {Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML)},
  journal = {Stem Cells Translational Medicine},
  year = {2025},
  volume = {14},
  number = {12},
  doi = {10.1093/stcltm/szaf062}
}
Kostenlos starten →